Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers

Journal of Human Virology

Volumn 1, Issue 1, 1997, Pages 52-57

  Elsana, Salem ^a   Shemer Avni, Yonat ^a   Sikuler, Etnanuel ^a   Sarov, Batia ^a   Naggan, Lechaim ^a   Bar Shany, Shulamith ^a   Gilon, Eliahu ^a   Yaari, Arieh ^a   Orgel, Mordechay ^a   Frazer, Gerald M ^a   Margalith, Miriam ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Enzyme linked immunosorbent assay (ELISA); Hepatitis B virus DNA; IgA anti HBc; IgM anti HBc; Polymerase chain reaction (PCR)

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; VIRUS DNA;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; FEMALE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; VIRUS REPLICATION;

BIOLOGICAL MARKERS; CARRIER STATE; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VIRUS REPLICATION;

EID: 0031261059     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Sarov I, Insler V, Sarov D, et al. Specific serum IgA antibodies in the diagnosis of active viral and chlamydial infections. In: Sanna A, Morace G, editors. New horizons in microbiology. Amsterdam: Elsevier Biomedical Press, 1984:157-168.
2. Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. J Med Virol 1986;20: 329-339.
3. Margalith M, Sarov B, Sarov I, et al. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Res Hum Retroviruses 1990;6:607-615.
4. Levy E, Saah A, Sarov B, Sarov I, Rinaldo C, Margalith M. Human immunodeficiency virus (HIV-1) IgA serum antibodies in a longitudinal study of HIV-1 infection and subsequent progression of the disease in homosexual men [abstract 399]. Abstracts of the Annual Meeting of the Institute of Human Virology. J AIDS Hum Retrovirol 1996:82.
5. Sarov I, Siqueira-Linhares M, Chardonnet Y, et al. Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology 1981;15:228-234.
6. Hadar T, Tovi F, Sarov B, Sidi J, Sarov I. Detection of specific IgA antibodies to varicella zoster virus in serum of patients with Ramsay-Hunt syndrome. Ann Otol Rhinol Laryngol 1990;99;461-465.
7. Piura B, Sarov I, Sarov B, Kleinman D, Chaim W, Insler V. Serum IgG and IgA antibodies specific for Chlamydia tracbomatis in salpingitis patients as determined by the immunoperoxidase assay. Eur J Epidemiol 1985;1:110-116.
8. Lunenfeld E, Shapiro BS, Sarov B, Sarov I, Insler V, Decherney AH. The association between chlamydial-specific IgG and IgA antibodies and pregnancy outcome in an in vitro fertilization program. J In Vitro Fertil Embryo Transf 1989;6:222-227.
9. Nomura M, Douchin M, Tokuda A, Sato F, Ito S, Kohli Y, Norio F. Clinical significance of immunoglobulin A antibody to hepatitis B Core antigen of polymeric and monomeric forms in chronic type B liver disease with acute exacerbation. Am J Gastroenterol 1988;83:1390-1394.
10. Thompson RA, Carter R, Stokes RP et al. Serum immunoglobulins, complement levels and autoantibodies in liver disease. Clin Exp Immunol 1973;14:335-346.
11. Tanaka M, Sato S, Fujyama S, et al. Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease. Dig Dis Sci 1995;40: 457-464.
12. Smith HM, Lau JYN, Davies SEM, Daniels H, Alexander GJM, Williams R. Significance of serum IgM anti-HBc in chronic hepatitis B virus infection. J Med Virol 1992;36: 16-20.
13. Marinos G, Smith HM, Naoumov NV, Williams R. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 1994;19:303-311.
14. Sallberg M, Norder H, Magnius LO. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol 1990;30:1-6.
15. Zeldis JB, Lee JH, Mamish D, et al. Direct method for detecting small quantities of hepatitis B virus DNA in serum and plasma using the polymerase chain reaction. J Clin Invest 1989;84:1503-1508.
16. Kroes ACM, Quint WGV, Heijtink RA. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. J Med Virol 1991; 35:96-100.
17. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis B-seronegative subjects. Lancet 1988;2:588-591.
18. Sikuler E, Keynan A, Hanuka N, Friedman MG, Sarov I. Detection and persistence of specific IgA antibodies in serum of patients with hepatitis A by capture radioimmu-noassay. J Med Virol 1983;11:287-294.
19. Lee SD, Lo KF, Wu JC, Tsai YT, Wang JY, Ting LP, Tong MJ. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology 1986;6:369-373.
20. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, Verme G. Chronic hepatitis in HB-sAg carriers with serum HBV DNA and anti-HBe. Gastroenterology 1986;90:1268-1273.
21. Brunetto MR, Stemler M, Schodel F, et al. Identification of HBV variants which cannot produce precore-derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989;21:151-154.
22. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of e antigen in patients with chronic HBV infection. Lancet 1989;2:588-591.
23. Gerlich WH. Conference on chronically evolving viral hepatitis. Clin Diagn Virol 1993;1:69-75.
24. Gonzalez S, Navas S, Madejon A, et al. Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C. J Med Virol 1995;45:168-173.
25. Porchon C, Kremsdorf D, Pol S, et al. Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis. J Hepatol 1992;16:184-189.
26. Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341:349-353.
27. Nomura M, Imai M, Tsuda F, et al. Immunoglobulin A antibody against hepatitis B core antigen in acute and persistent infection with hepatitis B virus. Gastroenterology 1985;89:1109-1113.
28. Hikata M, Tachibana K, Imai M, et al. Immunoglobulin A antibody against hepatitis B core antigen of polymeric and monomeric forms, as well as of IgA1 and IgA2 subclasses, in acute and chronic infection with hepatitis B virus. Hepatology 1986;6:625-627.
29. Mcfarlane IG, Chaggar K, Davies SE, Smith HM, Alexander GJM, Williams R. IgA class antibodies to hepatitis delta virus antigen in acute and chronic hepatitis Delta vims infections. Hepatology 1991;14:980-984.
30. Lazizi Y, Pillot J. Delayed clearance of HBV DNA detected by PCR in the absence of viral replication. J Med Virol 1993;39:208-213.